PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts - PubMed (original) (raw)
doi: 10.1016/j.yjmcc.2008.11.001. Epub 2008 Nov 13.
Osamu Tsukamoto, Tetsuo Minamino, Hiroshi Asanuma, Masashi Fujita, Yoshihiro Asano, Hiroyuki Takahama, Hideyuki Sasaki, Shuichiro Higo, Masanori Asakura, Seiji Takashima, Masatsugu Hori, Masafumi Kitakaze
Affiliations
- PMID: 19059265
- DOI: 10.1016/j.yjmcc.2008.11.001
PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts
Mitsutoshi Asai et al. J Mol Cell Cardiol. 2009 Apr.
Abstract
Proteasome regulates diverse cellular functions by eliminating ubiquitinated proteins. Protein kinase A (PKA) is a key regulator of proteasome activity. However, it remains unknown how PKA regulates proteasome activity and whether it controls proteasome activity in in vivo hearts. Both the in vitro peptidase assay and the in-gel peptidase assays showed that the treatment with PKA for 30 min dose-dependently activated purified 26S proteasome. Simultaneously, PKA treatment enhanced phosphorylation and assembly of purified 26S proteasome evaluated by non-reducing native polyacrylamide gel electrophoresis, either of which was blunted by the pretreatment with a PKA inhibitor, H-89. In in vivo canine hearts, proteasome assembly and activity were enhanced 30 min after the exogenous or endogenous stimulation of PKA by the intracoronary administration of isoproterenol or forskolin for 30 min or by ischemic preconditioning (IP) with 4 times of repeated 5 min of ischemia. The intracoronary administration of H-89 blunted the enhancement of proteasome assembly and activity by IP. Myocardial proteasome activity at the end of ischemia was decreased compared with the control, however, it did not differ from the control in dogs with IP. IP decreased the accumulation of ubiquitinated proteins in the canine ischemia/reperfusion myocardium, which was blunted by the intracoronary administration of a proteasome inhibitor, epoxomicin. However, proteasome activation by IP was not involved in its infarct size-limiting effects. These findings indicate that PKA rapidly enhances proteasome assembly and activity in in vivo hearts. Further investigation will be needed to clarify pathophysiological roles of PKA-mediated proteasome activation in ischemia/reperfusion hearts.
Similar articles
- Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C.
Sanada S, Asanuma H, Tsukamoto O, Minamino T, Node K, Takashima S, Fukushima T, Ogai A, Shinozaki Y, Fujita M, Hirata A, Okuda H, Shimokawa H, Tomoike H, Hori M, Kitakaze M. Sanada S, et al. Circulation. 2004 Jul 6;110(1):51-7. doi: 10.1161/01.CIR.0000133390.12306.C7. Epub 2004 Jun 21. Circulation. 2004. PMID: 15210595 - PKA-mediated eNOS phosphorylation in the protection of ischemic preconditioning against no-reflow.
Li XD, Cheng YT, Yang YJ, Meng XM, Zhao JL, Zhang HT, Wu YJ, You SJ, Wu YL. Li XD, et al. Microvasc Res. 2012 Jul;84(1):44-54. doi: 10.1016/j.mvr.2012.04.002. Epub 2012 Apr 14. Microvasc Res. 2012. PMID: 22542438 - Enhancement of Na+,K(+)-ATPase and Ca(2+)-ATPase activities in multi-cycle ischemic preconditioning in rabbit hearts.
Yorozuya T, Adachi N, Dote K, Nakanishi K, Takasaki Y, Arai T. Yorozuya T, et al. Eur J Cardiothorac Surg. 2004 Nov;26(5):981-7. doi: 10.1016/j.ejcts.2004.06.009. Eur J Cardiothorac Surg. 2004. PMID: 15519193 - Metabolic control of proteasome function.
Zhang F, Paterson AJ, Huang P, Wang K, Kudlow JE. Zhang F, et al. Physiology (Bethesda). 2007 Dec;22:373-9. doi: 10.1152/physiol.00026.2007. Physiology (Bethesda). 2007. PMID: 18073410 Review. - Emerging roles of proteasomes in ischemia-reperfusion injury of organs.
Kukan M. Kukan M. J Physiol Pharmacol. 2004 Mar;55(1 Pt 1):3-15. J Physiol Pharmacol. 2004. PMID: 15082863 Review.
Cited by
- S14-Phosphorylated RPN6 Mediates Proteasome Activation by PKA and Alleviates Proteinopathy.
Yang L, Parajuli N, Wu P, Liu J, Wang X. Yang L, et al. Circ Res. 2023 Sep 15;133(7):572-587. doi: 10.1161/CIRCRESAHA.123.322887. Epub 2023 Aug 29. Circ Res. 2023. PMID: 37641975 Free PMC article. - Targeting the secreted RGDKGE collagen fragment reduces PD‑L1 by a proteasome‑dependent mechanism and inhibits tumor growth.
Caron JM, Han X, Lary CW, Sathyanarayana P, Remick SC, Ernstoff MS, Herlyn M, Brooks PC. Caron JM, et al. Oncol Rep. 2023 Feb;49(2):44. doi: 10.3892/or.2023.8481. Epub 2023 Jan 12. Oncol Rep. 2023. PMID: 36633146 Free PMC article. - Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost.
Efentakis P, Andreadou I, Iliodromitis KE, Triposkiadis F, Ferdinandy P, Schulz R, Iliodromitis EK. Efentakis P, et al. Int J Mol Sci. 2022 Nov 15;23(22):14121. doi: 10.3390/ijms232214121. Int J Mol Sci. 2022. PMID: 36430599 Free PMC article. Review. - Advances in Proteasome Enhancement by Small Molecules.
George DE, Tepe JJ. George DE, et al. Biomolecules. 2021 Nov 30;11(12):1789. doi: 10.3390/biom11121789. Biomolecules. 2021. PMID: 34944433 Free PMC article. Review. - Physiological and pathological roles of protein kinase A in the heart.
Liu Y, Chen J, Fontes SK, Bautista EN, Cheng Z. Liu Y, et al. Cardiovasc Res. 2022 Jan 29;118(2):386-398. doi: 10.1093/cvr/cvab008. Cardiovasc Res. 2022. PMID: 33483740 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources